Expression of GATA-3 regulated by antisense oligonucleotide and inhaled corticosteroids in an asthma model in mice

LIU Li,CHENG Huan-ji,LU Ji-rong,QIA Hong-mei,FU Wen-yong,LIU Xiao-li
DOI: https://doi.org/10.3969/j.issn.1000-3606.2008.01.019
2008-01-01
Abstract:Objectives To investigate the regulatory roles of transcription factors GATA binding protein-3(GATA-3)in the pathogenesis of bronchial asthma,and to evaluate the effect of GATA-3 antisense oligonucleotide and steroid on the expression of GATA-3.Methods Forty female BALB/c mice were divided into 4 groups randomly:control group,asthma model group,steroid treatment group,and antisense oligonucleotide treatment group.The asthma model in mice was established by sensitization and challenge with ovalbumin.The expression of GATA-3 in lung tissues was detected by RT-PCR and Western blot.Results(1)It is confirmed,through the behavior changes of the mice,the increased eosinophil count in blood and bronchoalveolar lavage fluid,elevated serum IgE level,and the characteristic identification of pneumonic tissues sections,that the asthmatic mice model was established successfully.(2)The result of Western blot showed that the expression of GATA-3 in pneumonic tissues of asthmatic mice was higher than that of controls,and that it was decreased after treatment with steroid and GATA-3 antisense oligonucleotide.(3)The result from RT-PCR showed the same pattern as Western blot.Conclusions The data suggested that the expression of GATA-3 was higher in asthmatic mice than in controls,and GATA-3 may play a key role in airway inflammation.The treatment of asthma with steroids and GATA-3 antisense oligonucleotide may release airway infammation by down regulating the expression of GATA-3.GATA-3 antisense oligonucleotide may provide a novel approach to treating asthma.
What problem does this paper attempt to address?